Genmab A (GMAB) Total Current Liabilities: 2018-2021
- Genmab A's Total Current Liabilities fell 22.66% to $160.42 in Q2 2021 from the same period last year, while for Jun 2021 it was $160.42, marking a year-over-year decrease of 22.66%. This contributed to the annual value of $146.0 million for FY2020, which is 49.86% up from last year.
- Genmab A's Total Current Liabilities amounted to $160.42 in Q2 2021, which was down 100.00% from $146.0 million recorded in Q4 2020.
- Genmab A's Total Current Liabilities' 5-year high stood at $146.0 million during Q4 2020, with a 5-year trough of $160.42 in Q2 2021.
- In the last 3 years, Genmab A's Total Current Liabilities had a median value of $55.6 million in 2019 and averaged $59.8 million.
- Per our database at Business Quant, Genmab A's Total Current Liabilities surged by 98.79% in 2019 and then tumbled by 100.00% in 2020.
- Quarterly analysis of 4 years shows Genmab A's Total Current Liabilities stood at $49.0 million in 2018, then spiked by 98.79% to $97.4 million in 2019, then skyrocketed by 49.86% to $146.0 million in 2020, then decreased by 22.66% to $160.42 in 2021.
- Its last three reported values are $160.42 in Q2 2021, $146.0 million for Q4 2020, and $207.43 during Q2 2020.
